Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient

Int J Infect Dis. 2015 Aug:37:9-10. doi: 10.1016/j.ijid.2015.05.025. Epub 2015 Jun 9.

Abstract

The duration of a protective level of yellow fever antibodies after autologous hematopoietic stem cell transplantation in a previously vaccinated person is unclear. The case of a patient who had previously been vaccinated for yellow fever and who remained seropositive for 22 months after autologous peripheral blood stem cell transplantation for malignant lymphoma is described herein.

Keywords: Autologous hematopoietic stem cell transplantation; Bone marrow transplantation; Seropositivity; Vaccination; Yellow fever.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral / blood
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Jaundice / immunology
  • Jaundice / prevention & control
  • Jaundice / virology*
  • Lymphoma / surgery*
  • Male
  • Middle Aged
  • Transplantation, Autologous
  • Vaccination
  • Yellow Fever / immunology*
  • Yellow Fever Vaccine / administration & dosage
  • Yellow Fever Vaccine / immunology*

Substances

  • Antibodies, Viral
  • Yellow Fever Vaccine